Contract Manufacturing, Biopharmaceutical Production

November 20th 2024

SEKISUI has used a £15.7 million (US$20.7 million) investment to expand its clinical-grade drug substance manufacturing at its UK site.

November 12th 2024

Ascend is partnering with EW Healthcare Partners to expand capabilities in the United States.

October 8th 2024

According to the annual survey, four of the five biggest biologics capacity holders in 2028 will comprise CMOs, which are expected to have 45% of all CMO capacity in Asia.

October 7th 2024

The nanofiber microcarriers are the first of their kind for manufacturing viral vectors used in gene therapy production, according to Cellevate.